Western Financial Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-870
| Closed | -$620K | – | 134 |
|
|
2024
Q4 | $620K | Sell |
870
-833
| -49% | -$593K | 0.34% | 77 |
|
|
2024
Q3 | $1.79M | Sell |
1,703
-116
| -6% | -$122K | 1.02% | 23 |
|
|
2024
Q2 | $1.91M | Buy |
1,819
+12
| +0.7% | +$12.6K | 1.16% | 17 |
|
|
2024
Q1 | $1.74M | Buy |
1,807
+132
| +8% | +$127K | 1.07% | 22 |
|
|
2023
Q4 | $1.47M | Sell |
1,675
-81
| -5% | -$71.2K | 0.98% | 18 |
|
|
2023
Q3 | $1.45M | Sell |
1,756
-22
| -1% | -$18.1K | 1.06% | 17 |
|
|
2023
Q2 | $1.28M | Buy |
1,778
+14
| +0.8% | +$10.1K | 0.87% | 24 |
|
|
2023
Q1 | $1.45M | Buy |
1,764
+129
| +8% | +$106K | 1.03% | 13 |
|
|
2022
Q4 | $1.18M | Buy |
1,635
+672
| +70% | +$485K | 0.76% | 22 |
|
|
2022
Q3 | $663K | Buy |
963
+193
| +25% | +$133K | 0.46% | 48 |
|
|
2022
Q2 | $455K | Buy |
+770
| New | +$455K | 0.32% | 69 |
|